Abstract

Background:

Pregnancies in women with a unicornuate uterus are associated with an increased risk for specific adverse pregnancy and obstetric outcomes. We sought to investigate the obstetric outcomes of singleton pregnancies in nulliparous women with a unicornuate uterus in the third-trimester and to determine safe and appropriate modes of delivery.

Methods:

This retrospective cohort study included 94 nulliparous women with singleton pregnancies and a unicornuate uterus, along with 278 matched controls with a normally shaped uterus, from March 2009 to March 2019.

Results:

A total of 124 patients were diagnosed with a unicornuate uterus in the obstetrics department after the 28th week of pregnancy, including 94 nulliparous women. Compared to pregnancies with normal uterine morphology, a unicornuate uterus is associated with an increased risk of preterm delivery (PTD), preterm prelabor rupture of membranes (PPROM), malpresentation, caesarean section (CS), intrauterine growth restriction (IUGR), and neonatal intensive care unit (NICU) admission. Additionally, pregnancies with unicornuate uterus show significantly lower gestational age at delivery, as well as lower rates of term delivery and vaginal delivery. No increased risk was observed for in-labor CS rates or labor duration. In total, 17 pregnant women in the unicornuate uterus group had vaginal deliveries, including 2 who had previously undergone rudimentary horn resection.

Conclusions:

The presence of a unicornuate uterus is associated with an increased risk of specific adverse obstetric outcomes compared to pregnancies in women with a normal uterus. However, vaginal delivery may be considered in in women with a unicornuate uterus thorough evaluation.

1. Introduction

A unicornuate uterus is a rare congenital malformation resulting from the abnormal development of the Müllerian ducts. It is classified into two subclasses: a unicornuate uterus with a functional rudimentary horn, either communicating or non-communicating, and a unicornuate uterus without a rudimentary cavity [1]. According to the literature, the prevalence and morbidity rate of unicornuate uterus is 0.3% in the general population [2] and ranges from 5.0–13.0% in all Müllerian anomalies [3, 4]. Typically, a unicornuate uterus tends to be asymptomatic and undetected. While it is well established that pregnancies with unicornuate uterus are associated with various adverse pregnancy outcomes, including infertility, recurrent pregnancy loss, ectopic implantation, preterm delivery (PTD), preterm prelabor rupture of membranes (PPROM), malpresentation, caesarean section (CS), and intrauterine growth restriction (IUGR) [5, 6], the relationship between a unicornuate uterus and obstetric outcomes in the third-trimester has been infrequently studied, and reports of pregnancies reaching term or near term in these cases are rare.

Reduced cavity size and insufficient musculature may lead to uncoordinated uterine contractions, prolonged labor, and an increased rate of CS. Additionally, pregnant women with a unicornuate uterus may be reluctant to accept the risks of uterine rupture, injury from vaginal instrumental delivery, and potential fetal or neonatal death during vaginal delivery. Consequently, obstetricians may be reluctant to engage in cases involving potential medical disputes stemming from adverse obstetric outcomes. Therefore, they may be more inclined to choose CS as the mode of delivery in such situations. Although CS can save maternal and fetal lives, its overuse is associated with increased short- and long-term morbidity and mortality for both mothers and infants [7]. The global CS rate is 21.1% [8]. In China, the CS rate increased from 29% in 2008 to 35% in 2014 [9]. Although the CS rate has decreased with the implementation of the two-child policy, it remains high [10]. Since 2018, the CS rate in urban areas of China has consistently exceeded 40% [11]. With the implementation of the three-child policy in 2021, and in the light of the adverse health effects associated with CS, it is crucial to address the overuse of CS. Obstetricians should perform a risk assessment in pregnant women with a unicornuate uterus prior to delivery. Thus, this study aimed to further evaluate the impact of a unicornuate uterus on maternal and neonatal obstetric outcomes and to compare the results of different mode of delivery, in order to determine the safety and feasibility of vaginal delivery.

2. Materials and Methods
2.1 Patients

We performed a retrospective cohort analysis to determine the association between congenital unicornuate uteri and obstetric outcomes in nulliparous women during the third-trimester of pregnancy. The study was conducted at the Women’s Hospital, Zhejiang University School of Medicine. Data were from the obstetrics department between March 2009 and March 2019. The diagnosis of a unicornuate uterus was based on the European Society of Human Reproduction and Embryology/European Society for Gynaecological Endoscopy (ESHRE/ESGE) classification system, and it was defined as unilateral uterine with an incompletely formed or absent contralateral segment [1, 12]. The maternal uterine anatomy of the patients was evaluated using transvaginal ultrasonography (TVS), hysterosalpingography, hysteroscopy, and/or laparoscopy prior to this pregnancy. All nulliparous women with singleton pregnancies diagnosed with a unicornuate uterus were recruited for the study. As a tertiary obstetrics and gynecology hospital in China, we observed a substantial number of inpatients with normal uteri during the same time period. Therefore, we selected nulliparous singleton pregnancies with normal uteri from the midpoint of the study, specifically over a three-month period from March to May 2014. Only data from live newborns delivered after 28 weeks of gestation were included in the study. The following information was collected by trained obstetricians: demographics, gravidity and parity, history of infertility, abortion, ectopic pregnancy, and mode of conception. Intrapartum characteristics, including pregnancy comorbidities and complications, gestational age at delivery, mode of delivery, indications for CS, vaginal delivery, and neonatal outcomes, were also documented. The following outcomes related to vaginal delivery were assessed: the rate of vaginal delivery, forceps-assisted delivery, and in-labor CS, duration of labor, and blood loss. The following neonatal outcomes were assessed: birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission. Unless there is an absolute indication for a CS, the mode of delivery is determined collaboratively by the doctor and the patient. No patient exhibited additional intrauterine anomalies, such as a polyps, myomas, or adhesions. Furthermore, cervical or vaginal abnormalities were not present in any patients with unicornuate uteri included in this study. Multiple pregnancies, women with a history of CS delivery, those with unknown gestational age, and cases of fetal congenital malformations were excluded from the study. The study received approval from at the ethics committee of Women’s Hospital, Zhejiang University School of Medicine.

2.2 Definitions

Gestational age is determined from the first day of the last menstrual period (LMP). If the LMP is unknown or menstruation was irregular, ultrasound measurements are used to determine gestational age. In cases of in vitro fertilization, gestational age is determined based on the date of embryo transfer (ET). PTD is defined as a live birth occurring between 28 and 37 weeks of gestation. Term delivery is defined as delivery occurring between 37 to <42 weeks of gestation. PPROM is defined as rupture of membranes before 37 weeks of gestation. Small for gestational age (SGA) is defined as estimated fetal weight (EFW) or abdominal circumference below the 10th percentile for the gestational age, and IUGR is defined as the failure of the fetus to meet its growth potential due to pathological factors such as diseases of the mother, fetus, and placenta [13]. Low birth weight is defined as a birth weight <2500 g, while very low birth weight is defined as a birth weight <1500 g.

2.3 Statistical Analysis

Data were analyzed using SPSS version 23.0 (IBM Corp., Chicago, IL, USA). Descriptive statistics are presented as the mean ± standard deviation (SD) for continuous variables and median (interquartile interval) for non-continuous variables, and as percentages for categorical data. Student’s t-test and Mann–Whitney U test were used to compare continuous variables between the groups with and without normal distribution, respectively. The Chi-squared test or Fisher’s exact test was used to determine statistical significance between proportions. Multivariate binomial logistic regression analysis was used to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for maternal and neonatal outcomes associated with unicornuate uterus, adjusted for maternal age, body mass index (BMI), gravidity, and mode of conception. A p-value < 0.05 was considered statistically significant.

3. Results
3.1 Patient Demographics

From March 2009 to March 2019, a total of 124 patients were diagnosed with a unicornuate uterus in the obstetrics department after the 28th week of gestation. This group included 94 nulliparous women, 6 parous women, 22 patients who had undergone a previous CS, and 2 patients with a twin pregnancy. As mentioned earlier, 30 patients were excluded from this study, including parous women, those with a history of CS, and patients with a twin pregnancy. The uterine malformation was confirmed in 43 (45.74%) cases by TVS, in 6 (6.38%) cases by hysterosalpingography, and in 45 (47.87%) cases by hysteroscopy and/or laparoscopy. The distribution of the unicornuate uteri variants included 27 (28.70%) of left-unicornuates and 36 (38.30%) of right-unicornuates. The baseline patient characteristics are shown in Table 1. The unicornuate group and the control group were statistically similar regarding mean maternal age (29.29 ± 3.22 vs. 29.02 ± 3.53 years, p = 0.520), BMI (26.44 ± 3.48 vs. 26.24 ± 3.35 kg/m2, p = 0.612), gravidity (2 vs. 2, p = 0.065), dysmenorrhea (10.6% vs. 15.8%, p = 0.217), and abortion rates, which included the history of recurrent spontaneous abortion, spontaneous abortion, and induced abortion. The induced abortions were either requested by the patients or performed for social reasons. However, patients with unicornuate uteri exhibited higher rates of primary infertility (8.5% vs. 2.2%, p = 0.013) and prior ectopic pregnancy (12.8% vs. 1.4%, p < 0.001) compared to the control group. Among the unicornuate uterus group, a total of 11 patients had experienced a prior ectopic pregnancy, including 6 patients who had undergone rudimentary horn resection prior to the pregnancy included in this study.

Table 1. Clinical characteristics of women with a unicornuate uterus and control subjects.
Characteristics Unicornuate (n = 94) Control (n = 278) p-value
Maternal age, years 29.29 ± 3.22 29.02 ± 3.53 0.520
BMI (kg/m2) 26.44 ± 3.48 26.24 ± 3.35 0.612
Gravidity 2 (1–6) 2 (1–5) 0.065
Dysmenorrhea 10/94 (10.6%) 44/278 (15.8%) 0.217
Primary infertility 8/94 (8.5%) 6/278 (2.2%) 0.013
History of recurrent spontaneous abortion 2/94 (2.1%) 2/278 (0.7%) 0.571
History of spontaneous abortion 7/94 (7.4%) 30/278 (10.8%) 0.349
History of induced abortion 22/94 (23.4%) 63/278 (22.7%) 0.882
Prior ectopic pregnancy 12/94 (12.8%) 4/278 (1.4%) <0.001
Assisted reproduction 16/94 (17.0%) 11/278 (4.0%) <0.001

Values are the number n (%) or mean ± SD or median (minimum to maximum).

BMI, body mass index; SD, standard deviation.

3.2 Pregnancy and Obstetric Outcomes in the Unicornuate and Control Groups

Perinatal outcomes of the study group are shown in Table 2. Compared with the control group, the unicornuate group had significantly higher rates of PTD (21.3% vs. 6.8%, p < 0.001), prelabor rupture of membranes (PROM) (24.5% vs. 13.7%, p = 0.015), PPROM (17.0% vs. 2.2%, p < 0.001), malpresentation (48.9% vs. 6.1%, p < 0.001), and CS (81.9% vs. 32.0%, p < 0.001). However, the gestational age at delivery (37.51 ± 2.70 vs. 38.94 ± 2.67 weeks, p < 0.001), the term delivery rate (78.7% vs. 93.2%, p < 0.001), and the rate of vaginal delivery (12.8% vs. 64.0%, p < 0.001) were significantly lower in the unicornuate group than in the normal controls. A total of 17 pregnant women in the unicornuate group delivered vaginally, 5 of whom underwent a forceps delivery. The rates of CS during labor and blood loss were not statistically significant.

Table 2. Obstetric outcomes of women with a unicornuate uterus and control subjects.
Unicornuate (n = 94) Control (n = 278) p-value
Gestational age at delivery (weeks) 37.51 ± 2.70 38.94 ± 2.67 <0.001
<33+6 w 2/94 (2.1%) 7/278 (2.5%) 1
34–36+6 w 18/94 (19.1%) 12/278 (4.3%) <0.001
>37 w 74/94 (78.7%) 259/278 (93.2%) <0.001
PROM 23/94 (24.5%) 38/278 (13.7%) 0.015
PPROM 16/94 (17.0%) 6/278 (2.2%) <0.001
Malpresentation 46/94 (48.9%) 17/278 (6.1%) <0.001
Mode of delivery
Vaginal delivery 12/94 (12.8%) 178/278 (64.0%) <0.001
Forceps delivery 5/94 (5.3%) 11/278 (4.0%) 0.788
CS 77/94 (81.9%) 89/278 (32.0%) <0.001
Blood loss (mL) 248.40 ± 87.51 236.80 ± 110.60 0.301

Values are number n (%) or mean ± SD. CS, caesarean section; PROM, prelabor rupture of membranes; PPROM, preterm prelabor rupture of membranes; SD, standard deviation.

3.3 Neonatal Outcomes

Neonates in the unicornuate group were characterized by a lower birth weight than that observed in controls (2980.74 ± 518.61 g vs. 3229.57 ± 504.98 g, p < 0.001), even when excluding premature births (3149.05 ± 393.14 g vs. 3309.88 ± 382.05 g, p = 0.002). Adverse neonatal outcomes, such as birth weight <2500 g (18.1% vs. 2.9%, p < 0.001), IUGR or SGA (10.6% vs. 3.2%, p = 0.011), and NICU admission (12.8% vs. 3.6%, p = 0.001) were significantly higher in women with a unicornuate uterus. There was no significant difference in Apgar scores between the two groups, and no intrauterine fetal death were observed in either group (Table 3).

Table 3. Neonatal outcomes.
Unicornuate (n = 94) Control (n = 278) p-value
Weight (g) 2980.74 ± 518.61 3229.57 ± 504.98 <0.001
>2500 76/94 (80.9%) 267/278 (96.0%) <0.001
<2500 17/94 (18.1%) 8/278 (2.9%) <0.001
<1500 1/94 (1.1%) 3/278 (1.1%) 1
Weight at different gestational weeks (g)
<33+6 w 1755.00 ± 558.61 1514.29 ± 327.90 <0.001
34–36+6 w 2425.00 ± 402.77 2496.67 ± 573.80 0.263
>37 w 3149.05 ± 393.14 3309.88 ± 382.05 0.002
Apgar scores
<7 at 1 min 2/94 (2.1%) 4/278 (1.4%) 1
<7 at 5 min 0 1/278 (0.4%) 1
IUGR or SGA 10/94 (10.6%) 9/278 (3.2%) 0.011
NICU 12/94 (12.8%) 10/278 (3.6%) 0.001

Values are number n (%) or mean ± SD.

IUGR, intrauterine growth restriction; SGA, small for gestational age; NICU, neonatal intensive care unit; SD, standard deviation.

3.4 Maternal and Neonatal Outcomes Associated with Unicornuate Uterus

In a multivariate binomial logistic regression analysis model, after controlling for potential confounding factors such as maternal age, BMI, gravidity, and mode of conception, the unicornuate group was found to be at higher risk for PTD (adjusted OR [aOR]: 3.12, 95% CI: 1.53–6.36), PROM (aOR: 1.96, 95% CI: 1.06–3.61), PPROM (aOR: 7.81, 95% CI: 2.82–21.66), malpresentation (aOR: 14.56, 95% CI: 7.55–28.06) and CS (aOR: 11.66, 95% CI: 6.13–22.18). The unicornuate group remained at higher risk for IUGR or SGA (aOR: 3.09, 95% CI: 1.16–8.24) and NICU (aOR: 3.21, 95% CI: 1.28–8.06) (Table 4).

Table 4. Maternal and neonatal outcomes associated with unicornuate uterus.
Unicornuate (n = 94) Control (n = 278) Crude OR (95% CI) aOR (95% CI)# p-value
Maternal outcome
PTD 20 (21.3%) 19 (6.8%) 3.69 (1.87–7.27) 3.12 (1.53–6.36) 0.002
PROM 23 (24.5%) 38 (13.7%) 2.05 (1.14–3.66) 1.96 (1.06–3.61) 0.032
PPROM 16 (17.0%) 6 (2.2%) 9.30 (3.52–24.57) 7.81 (2.82–21.66) <0.001
Malpresentation 46 (48.9%) 17 (6.1%) 14.71 (7.79–27.79) 14.56 (7.55–28.06) <0.001
CS 77 (81.9%) 89 (32.0%) 9.62 (5.37–17.22) 11.66 (6.13–22.18) <0.001
Forceps delivery 5 (5.3%) 11 (4.0%) 1.36 (0.46–4.03) 1.25 (0.38–4.07) 0.712
Vaginal delivery 12 (12.8%) 178 (64.0%) 0.08 (0.04–0.16) 0.07 (0.04–0.15) <0.001
Neonatal outcome
IUGR or SGA 10 (10.6%) 9 (3.2%) 3.56 (1.40–9.05) 3.09 (1.16–8.24) 0.024
NICU 12 (12.8%) 10 (3.6%) 3.92 (1.64–9.41) 3.21 (1.28–8.06) 0.013

Values are number n (%) or mean ± SD.

#Results were adjusted for maternal age, BMI, gravidity, and mode of conception.

OR, odds ratio; aOR, adjusted odds ratio; CI, confidence interval; PTD, preterm delivery; PROM, prelabor rupture of membranes; PPROM, preterm premature rupture of membranes; CS, caesarean section; IUGR, intrauterine growth restriction; SGA, small for gestational age; NICU, neonatal intensive care unit; SD, standard deviation; BMI, body mass index.

3.5 Indication for CS and Vaginal Delivery Outcomes

Malpresentation was a more common indication for CS in patients with a unicornuate uterus compared to controls (59.7% vs. 19.1%, p < 0.001). Among the 77 patients, 6 underwent emergency CS due to non-reassuring fetal status during vaginal delivery or threatened uterine rupture. Most CS performed on patients with a normal uterus were emergency procedures due to failure of progress in labor (11.2%) or fetal heart rate abnormalities or intrapartum meconium (28.1%). As an indication of uterine anomalies in patients with a unicornuate uterus, 4 out of 20 underwent CS due to previous uterine surgery (laparoscopic resection of rudimentary horn), while the remaining patients rejected vaginal delivery due to concerns about the risks associated with labor (Table 5).

Table 5. Indication of CS in patients with a unicornuate uterus and control subjects.
Unicornuate (n = 77) Control (n = 89) p-value
Malpresentation 46/77 (59.7%) 17/89 (19.1%) <0.001
Failure of progress 0 10/89 (11.2%) 0.007
Fetal heart rate abnormalities or intrapartum meconium 5/77 (6.5%) 25/89 (28.1%) <0.001
Threatened uterine rupture 1/77 (1.3%) 0 0.464
Intrauterine infection 0 8/89 (9.0%) 0.020
Severe pre-eclampsia 3/77 (3.9%) 10/89 (11.2%) 0.079
Severe intrahepatic cholestasis of pregnancy 0 4/89 (4.5%) 0.169
Oligohydramnios 0 2/89 (2.2%) 0.500
Cord around neck 3 rounds 2/77 (2.6%) 1/89 (1.1%) 0.899
Placental abruption 0 2/89 (2.2%) 0.500
Uterine anomalies 20/77 (26.0%) 0 <0.001

Values are number n (%). CS, caesarean section.

The incidence of forceps delivery during labor was higher in the unicornuate uterus group compared to normal controls (23.8 % vs. 4.8%, p = 0.003). However, there were no significant differences in the indications for forceps delivery, the duration of labor in the first and second stages, blood loss, and the rate of in-labor CS between the groups (Table 6). Two pregnant women in the unicornuate uterus group achieved successful vaginal deliveries following rudimentary horn resection.

Table 6. Vaginal delivery outcomes.
Unicornuate (n = 21) Control (n = 230) p-value
Delivery onset
Spontaneous 18/21 (85.7%) 198/230 (86.1%) 1
Induction of labor 3/21 (14.3%) 32/230 (13.9%) 1
Vaginal delivery 12/21 (57.1%) 178/230 (77.4%) 0.038
Forceps delivery 5/21 (23.8%) 11/230 (4.8%) 0.003
In-labor CS 4/21 (19.0%) 41/230 (17.8%) 1
Indication of forceps delivery
Fetal heart rate abnormalities or intrapartum meconium 2/5 (40.0%) 7/11 (63.6%) 0.596
Prolonged second-stage labor 3/5 (60.0%) 4/11 (36.4%) 0.596
Labor length of first stage (min) 300 (205, 502.5) 425 (265, 640) 0.158
Labor length of second stage (min) 56 (33, 104.5) 51 (27.5, 85.5) 0.478
Blood loss (mL) 250 (150, 375) 200 (150, 300) 0.091

Values are number n (%) or mean ± SD or median (interquartile interval). CS, caesarean section; SD, standard deviation.

3.6 Outcomes of Unicornuate Uterus by Delivery Method

In order to compare the outcomes of different delivery modes in the unicornuate uterus group, we found no significant differences in gestational age at delivery, birth weight, NICU admission, or blood loss between vaginal delivery (including vaginal instrumental delivery) and CS (Table 7).

Table 7. The outcome of unicornuate uterus for different modes of delivery.
Vaginal delivery (contain vaginal instrumental delivery, n = 17) CS (n = 77) p-value
Gestational age at delivery (weeks) 38.29 ± 1.85 37.81 ± 1.72 0.301
<33+6 w 0 2/77 (2.60%) 1
34–36+6 w 2/17 (11.76%) 16/77 (20.78%) 0.607
>37 w 15/17 (88.24%) 59/77 (76.62%) 0.465
weight (g) 2982.94 ± 417.31 2980.26 ± 540.79 0.985
<33+6 w - 1755.00 ± 558.61 -
34–36+6 w 2185.22 ± 261.63 2377.22 ± 469.23 0.107
>37 w 3089.33 ± 301.74 3164.24 ± 414.00 0.514
NICU 2/17 (11.76%) 10/77 (12.99%) 1
Blood loss (mL) 279.41 ± 137.00 241.56 ± 71.82 0.107

Values are number n (%) or mean ± SD.

CS, caesarean section; NICU, neonatal intensive care unit; SD, standard deviation.

4. Discussion

Among all Müllerian anomalies, uterine anomalies are most commonly associated with poor obstetric outcomes. Previous studies investigating the impact of a unicornuate uterus on obstetric outcomes have reported higher incidences of PTDs, PPROM, IUGR, malpresentation, and CS [5, 14]. Researchers have proposed various theories on the underlying causes of poor obstetric outcomes. Uterine malformations are linked to a reduced uterine cavity volume, inadequate muscular development, compromised capacity for expansion, irregular myometrial and cervical function, insufficient blood supply, and irregular endometrial growth. These factors may lead to complications in fetal development, pregnancy, and childbirth, increasing the risk of preterm birth and other adverse events for both the pregnant woman and the fetus [15, 16].

Compared to women with a normal uterus, those with a unicornuate uterus had a significantly higher rate of primary infertility in the study. Reduced fertility might be attributed to diminished uterine muscle tissue or a lack of blood vessels, which can lead to inadequate nourishment for the developing fetus [3]. However, the relationship between unicornuate uterus and infertility remains controversial. The causes of infertility may included female factors, male factors, combined factors, and unknown factors [17]. Patients with a unicornuate uterus have a good chance to conceiving through in vitro fertilization and embryo transfer (IVF-ET) or intracytoplasmic sperm injection [18].

The gestational age at delivery in the unicornuate uterus group was lower than that in control group. In individuals with a unicornuate uterus, gestational capacity is compromised due to the presence of only a partial uterine muscle structure [19]. In such congenital conditions, the uterine walls are thinner than those of normal uteri, and myometrial thickness further decreases as the pregnancy progresses, leading to unevenness across the uterine surface [20]. This reduction in muscular support, combined with irregularities in the uterine cavity’s shape, significantly contributes to the risks of both PROM and premature delivery.

Our study found an increased risk of IUGR or SGA in patients with unicornuate uterus, and the birth weight of their babies was significantly lower than that of the control group. IUGR or SGA are similarly attributed to disruptions in uterine blood flow, which may be result from absent or irregular uterine or ovarian arteries, as well as a reduced uterine cavity size [19]. Although there was no significant difference in birth weight between the two groups across different gestational weeks before term birth, following the current American Congress of Obstetrics and Gynecology guidelines for management of IUGR [21], it is advisable to consider serial growth ultrasound examinations to screen for IUGR in pregnancies complicated by maternal Müllerian anomalies.

Higher rates of caesarean deliveries were mainly attributable to nonvertex presentation and excessive concerns among parents. In China, prior to the introduction of the two-child policy, pregnant women with a unicornuate uterus were particularly concerned about the risk of being transferred to an in-labor CS due to the potential threat of uterine rupture. In the study by Fox et al. [14], patients who went into labor and for whom vaginal delivery was attempted showed a statistical trend toward an increased risk of CS, based on the severity of the uterine abnormality. To investigated the relationship between unicornuate uterus and the risk of vaginal delivery, we compare the rates of vaginal births among primiparous women in the study and control groups. However, our study found no association with threatened uterine rupture, preeclampsia, or placental abruption. Importantly, our results showed no significant increase in CS rates among women undergoing a trial of labor. In addition, there was no increased risk of prolonged labor or postpartum bleeding in unicornuate uterus group. NICU admissions did not increase in unicornuate uterus group across different modes of delivery. Erez et al. [22] also addressed the safety of vaginal delivery, noting that they observed no increased incidence of uterine rupture among women with Müllerian duct abnormalities who underwent a trial of labor following a CS. With the implementation of the two-child policy, more pregnant women are choosing vaginal delivery to avoid the adverse consequences associated with CS. This discovery is of significant value, potentially aiding obstetricians in alleviating concerns for women with a unicornuate uterus who are in active labor, by reinforcing their likelihood of achieving a successful vaginal delivery.

A study has reported that a unicornuate uterus is associated with a rudimentary horn in 70–90% of cases [23], which was consistent with our study. The rudimentary uterine horn has historically been recognized as a risk factor for ectopic pregnancies. The rudimentary horn cavity may or may not communicate with the primary uterine cavity. This poses a risk of rupture, as most individuals with a rudimentary horn are asymptomatic and lack a connection to the vagina. For this reason, many obstetricians and gynecologists recommend the preventive removal of the rudimentary horn to mitigate the risk of ectopic pregnancy within the horn [24]. This may also expose women to the risk of uterine rupture during pregnancy. However, Sawada et al. [25] noted that among the 6.6% of patients who underwent rudimentary horn removal, there were no instances of uterine rupture either before or after labor. In a case study detailed by Kanno et al. [26], a woman conceived naturally just four months after laparoscopic removal of the rudimentary horn. The pregnancy proceeded without any complications, culminating in the vaginal delivery of a healthy 3770 g infant at full term, 40 weeks. In our study, two pregnant women who had their residual horn removed due to prior residual horn pregnancies underwent successful vaginal deliveries at 39 and 40 weeks (birth weights 3170 g and 3450 g, respectively). However, the data are very limited, so careful risk assessment is important before attempting vaginal delivery. The mode of delivery should be determined according to the specific circumstances, and fetal heart rate monitoring during vaginal delivery should be strengthened toreduce maternal and neonatal complications.

There are few previous well-controlled studies assessing the risk of uterine rupture before or during labor in pregnant woman with a unicorned uterus. Therefore, the optimal timing and mode of delivery remain uncertain. Vaginal delivery did not increase the risk of prolonging either the first or second stages of labor, nor did it affect the rate of vaginal instrumental deliveries. In the study, the choice of delivery method was determined through consultation between the patient and her doctor. We concluded that patients with a unicornuate uterus did not present an extremely high risk for uterine rupture before labor. However, given the limited number of cases in our study, additional research is necessary to accurately evaluate the risk of uterine rupture in these patients. In our study, out of 94 patients, 21 expressed a desired for vaginal delivery, and 12 of them successfully delivered vaginally without any complications. There was no significant difference in maternal and infant outcomes among the different delivery modes in unicornuate uterus groups. These results indicate that vaginal deliveries are possible, provided that the patients are meticulously assessed for their suitability. Besides, in clinical practice, the possibility of uterine rupture should be considered, with heightened attention to early signs to facilitate the early diagnosis of pre-rupture conditions in the unicornuate uterus or the rudimentary horns.

The strengths of this study include our attempt to explore obstetric outcomes in nulliparous women with unicornuate uterus during the third-trimester. We believe that our research provides significant value to the clinical management of this rare condition. The main limitation of our study is its retrospective design and relatively small sample size; therefore, prospective investigations with larger cohorts are warranted in the future. Another potential weakness is the non-random selection of the control group, which may introduce selection and confounding biases. However, we adjusted for several possible confounders in the multivariate binomial logistic regression analysis model. The conclusions were consistent with the univariate analysis, which guaranteed statistical power.

5. Conclusions

In summary, a unicornuate uterus is associated with adverse obstetric outcomes for women with singleton pregnancies. These pregnant patients should be informed that they may require proactive and intensive long-term obstetric management. Our study demonstrates that women with a unicornuate uterus can achieve vaginal delivery more successfully following careful evaluation. Unicornuate uterus is not an absolute indication for sections. Physicians should inform patients about the risks associated with labor, establish confidence in vaginal delivery, strengthen labor monitoring, ensure the safety of both mothers and neonates, and improve the success rate of vaginal deliveries.

Availability of Data and Materials

Obtain availability of data and materials through corresponding author email.

Author Contributions

LW, YY, JX and XJH designed the research study. LW, YY, YQZ, JX and XJH performed the research and experimental protocols. LW, YY, YQZ and XJH analyzed the data and statistics. LW and XJH wrote the manuscript. LW, JX and XJH made the critical review of the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

The present study was approved by the Ethics Committee of Women’s Hospital, School of Medicine, Zhejiang University (approval number: IRB-20240274-R), and informed consent was obtained from all the included participants. This study was conducted in accordance with the Helsinki Declaration.

Acknowledgment

We would like to express our gratitude to all those who helped us during the writing of this manuscript. Thanks to all the peer reviewers for their opinions and suggestions.

Funding

This research received no external funding.

Conflict of Interest

The authors declare no conflict of interest.

References

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.